Neoadjuvant ICI Without Chemotherapy Demonstrates Potential Efficacy in Patients with Early-Stage TNBC By Ogkologos - November 21, 2024 950 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the BELLINI study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Allogeneic Regulatory T Cell-Based Immunotherapy with HSPC and T Cells-vldq for Use in Matched Donor HSCT for Adult Patients with Haematologic Malignancies Combination of mFOLFOX6/Bevacizumab Plus Atezolizumab Prolongs PFS Compared with Atezolizumab in First-Line Treatment of dMMR/MSI-H mCRC Use of YEARS Algorithm, D-dimer Levels, and Performing Risk-Dependent CT Pulmonary Angiography is Safe in Patients with Cancer and Suspected Pulmonary Embolism MOST POPULAR Steroids May Limit the Effectiveness of Immunotherapy for Brain Cancer December 28, 2020 FDA Approves Alpelisib for PIK3CA-Related Overgrowth Spectrum April 13, 2022 Rescue Cat Alerts Mom to Breast Cancer by “Aggressively” Cuddling Her... May 11, 2021 FDA Expands Endometrial Cancer Indication for Dostarlimab-gxly with Chemotherapy September 5, 2024 Load more HOT NEWS New Treatment Combinations Slow Progression of Prostate Cancer and Stomach and... Mom with Breast Cancer Who Had A Year to Live Goes... Sotorasib in Combination with Panitumumab Results in Longer PFS in Patients... High Tumour Mutation Burden Fails to Predict Response to Immune Checkpoint...
